Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.
about
Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin.Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice.Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo.
P2860
Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of oral vaccines a ...... nic Escherichia coli diarrhea.
@en
Development of oral vaccines a ...... nic Escherichia coli diarrhea.
@nl
type
label
Development of oral vaccines a ...... nic Escherichia coli diarrhea.
@en
Development of oral vaccines a ...... nic Escherichia coli diarrhea.
@nl
prefLabel
Development of oral vaccines a ...... nic Escherichia coli diarrhea.
@en
Development of oral vaccines a ...... nic Escherichia coli diarrhea.
@nl
P921
P1476
Development of oral vaccines a ...... nic Escherichia coli diarrhea.
@en
P577
1990-01-01T00:00:00Z